Lilly to build $2.5 billion diabetes drug plant in Germany
By Klaus Lauer and Ludwig Burger Eli Lilly will build its first plant in Germany for 2.3 billion
2023-11-17 21:45
Lilly extends tender offer to acquire Point Biopharma to Dec 1
Eli Lilly said on Friday it was extending the deadline for its tender offer for Point Biopharma shares
2023-11-17 20:21
Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
2023-11-09 21:53
Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion
(Reuters) -Eli Lilly and Co will buy cancer therapy developer Point Biopharma Global for $1.4 billion, the companies said on
2023-10-03 19:25
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
By Blake Brittain Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5
2023-09-27 05:17
Uninsured US patients pay up to $330 for Eli Lilly’s $25 insulin, Senator Warren says
By Patrick Wingrove Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite
2023-07-13 19:24